Martingale Asset Management »

Crinetics Pharmaceuticals In shares owned by Martingale Asset Management

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Martingale Asset Management from 13F filings

Historical chart of Martingale Asset Management investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Martingale Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Martingale Asset Management

Quarter filed Position value Share count Share price at filing
2025-03-31 $225k 6.7k 33.54
2024-12-31 $1.1M 23k 51.13
2024-09-30 $1.1M 22k 51.10
2023-09-30 $1.3M 44k 29.74
2023-06-30 $868k 48k 18.02
2023-03-31 $774k 48k 16.06
2022-12-31 $836k 46k 18.30